Morbidity and Mortality Weekly Report (MMWR)

This report describes the effectiveness of the third dose of Pfizer-BioNTech and Moderna vaccines in preventing hospitalizations.

This report provides a detailed summary of data from NVDRS on violent deaths that occurred in 2018.

This report describes disease severity and healthcare utilization during the emergence of the Omicron variant of the virus that causes COVID-19 in the U.S.

This report describes COVID-19 incidence rate ratios for unvaccinated versus fully vaccinated persons with and without booster vaccine doses during the emergence of the Omicron variant.

This report describes COVID-19 cases and hospitalizations by vaccination status and previous COVID-19 diagnosis before and after the Delta variant became predominant.

This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods.

This report summarizes health data reported to the Electronic Disease Notification system for refugees, immigrants, and eligible others who arrived in the United States during 2014–2019.

This report describes the percentage of children with more than two hours of screen time per weekday.

This report describes early evidence of the Omicron variant in community wastewater.

This report describes updated recommendations from the ACIP to the use of Janssen mRNA COVID-19 vaccines.

This report describes a decrease in wild poliovirus type 1 during 2021 among children in Afghanistan.

This report describes the frequency of individual Zika-associated birth defects from the U.S. Zika Pregnancy and Infant Registry.

This report describes the ACIP recommendations for two doses of RZV to prevent herpes zoster and related complications in immunocompromised adults.

This report describes racial and ethnic disparities in receiving medications for COVID-19 treatment.

Guidelines for developing CDC evidence-based guidelines

This report describes a Kanawha County HIV outbreak during the COVID-19 pandemic among people who inject drugs.

This report describes trends in breast cancer incidence among women.

This report describes HIV prevalence among young women in Lesotho.

This report describes the percentage of adults who received care at home from a friend or family member.

This report describes an evaluation of state-led surveillance of neonatal abstinence syndrome.

This report describes how children and adolescents were more likely to receive a new diabetes diagnosis after infection with SARS-CoV-2, the virus that causes COVID-19.

This report describes how effective Pfizer-BioNTech COVID-19 vaccination was against multisystem inflammatory syndrome in children (MIS-C).

2015–2019 National Survey on Drug Use and Health data regarding national-, regional-, and state-level prevalence of suicidal thoughts, planning, and attempts.

This report describes emergency department visits made by adults by age and chronic conditions.

This report describes the percentage of adults in the United States who met fruit and vegetable intake recommendations.

This report describes three human deaths attributed to rabies from bat exposures.

This report describes risk factors for severe COVID-19 outcome among vaccinated people.

This report describes the percentage of pregnant adults who reported binge drinking during pregnancy.

This report describes firearm deaths in major metropolitan areas in the United States.

This report describes how COVID-19 vaccination during pregnancy was not associated with preterm or small-for-gestational-age at birth compared with unvaccinated pregnant women.

This report describes safety of the Pfizer-BioNTech COVID-19 vaccine for children aged 5–11 years.

This report describes the percentage of children and adolescents who received an influenza vaccine in the past 12 months.

This report describes outcomes of children and adolescents

This report describes interim estimate of vaccine effectiveness among adolescents who received the COVID-19 Pfizer-BioNTech vaccine.

This report describes schools in Illinois implementing COVID-19 Test to Stay programs to continue in-person school learning.

This report describes a COVID-19 Test to Stay strategy in Los Angeles schools to continue in-person learning.

This report describes an investigation on an Omicron variant cluster in a Nebraska household from November–December 2021.

This report describes a COVID-19 Test to Stay strategy in Los Angeles schools to continue in-person learning.

This report describes schools in Illinois implementing COVID-19 Test to Stay programs to continue in-person school learning.

This report describes the initial spread and impact of the Omicron COVID-19 variant in the U.S.

This report describes receipt of booster or additional primary COVID-19 vaccine doses.

This report describes hours spent by primary care and specialist care physicians documenting clinical care outside normal office hours.

This report describes drug overdose deaths from illicitly manufactured fentanyls during 2019–2020

This report describes effectiveness of health care providers’ recommendations of COVID-19 vaccination recommendations.

This report describes mucormycosis cases in Honduras during the COVID-19 pandemic.

This report describes cases of COVID-19-associated Mucormycosis in Arkansas.

This report describes drug overdose deaths from illicitly manufactured fentanyls during 2019–2020

This report describes receipt of booster or additional primary COVID-19 vaccine doses.

This report describes the initial spread and impact of the Omicron COVID-19 variant in the U.S.

This report describes the percentage of employed adults who work closer than 6 feet from another person at their main job.